|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0012772,
umls-concept:C0014582,
umls-concept:C0016360,
umls-concept:C0017185,
umls-concept:C0023413,
umls-concept:C0024623,
umls-concept:C0086409,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0282460,
umls-concept:C1513040,
umls-concept:C1521750,
umls-concept:C1521808
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1994-2-17
|
|
pubmed:abstractText |
Metastatic disease is a common problem in gastric cancer and the development of better chemotherapeutic regimens is a clear priority in gastrointestinal oncology.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
753-7
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8280656-Adult,
pubmed-meshheading:8280656-Aged,
pubmed-meshheading:8280656-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8280656-Cisplatin,
pubmed-meshheading:8280656-Epirubicin,
pubmed-meshheading:8280656-Female,
pubmed-meshheading:8280656-Fluorouracil,
pubmed-meshheading:8280656-Humans,
pubmed-meshheading:8280656-Leucovorin,
pubmed-meshheading:8280656-Male,
pubmed-meshheading:8280656-Middle Aged,
pubmed-meshheading:8280656-Stomach Neoplasms
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
|
|
pubmed:affiliation |
Dept. of Hematology and Medical Oncology, Hospital Clínico Universitario, Facultad de Medicina, Valencia, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
